S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
S&P 500   4,410.13 (+0.28%)
DOW   34,364.50 (+0.29%)
QQQ   353.30 (+0.46%)
AAPL   161.62 (-0.49%)
MSFT   296.37 (+0.11%)
FB   308.71 (+1.83%)
GOOGL   2,616.08 (+0.35%)
AMZN   2,890.88 (+1.33%)
TSLA   930.00 (-1.47%)
NVDA   233.72 (+-0.01%)
BABA   120.37 (-2.32%)
NIO   24.87 (-9.07%)
AMD   116.53 (-1.92%)
CGC   7.40 (+1.51%)
MU   82.95 (+1.24%)
GE   96.91 (+0.63%)
T   26.34 (-1.01%)
F   20.39 (-1.26%)
DIS   137.46 (+0.06%)
AMC   16.64 (-7.40%)
PFE   51.54 (-2.37%)
ACB   4.32 (-3.14%)
BA   204.20 (-0.60%)
NASDAQ:MDJH

MDJM Stock Forecast, Price & News

$1.81
-0.04 (-2.16%)
(As of 01/24/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.71
$1.86
50-Day Range
$1.67
$3.54
52-Week Range
$1.62
$8.60
Volume
9,611 shs
Average Volume
8,234 shs
Market Capitalization
$21.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.61
30 days | 90 days | 365 days | Advanced Chart
Receive MDJH News and Ratings via Email

Sign-up to receive the latest news and ratings for MDJM and its competitors with MarketBeat's FREE daily newsletter.


MDJM logo

About MDJM

Mdjm Ltd. is a holding company. Through Tianjin Mingda Jiahe Real Estate Co. Ltd., it provides real estate agency services. Its services include real estate consulting services,and independent training. The company was founded on January 26, 2018 and is headquartered in Tianjin, China.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Real estate agents & managers
Sub-Industry
N/A
Sector
Finance
Current Symbol
NASDAQ:MDJH
Fax
N/A
Employees
174
Year Founded
N/A

Sales & Book Value

Annual Sales
$5.87 million
Cash Flow
$0.02 per share
Book Value
$0.78 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$21.07 million
Optionable
Not Optionable

Company Calendar

Today
1/24/2022
Next Earnings (Estimated)
4/15/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

0.77 out of 5 stars

Finance Sector

1282nd out of 1,355 stocks

Real Estate Agents & Managers Industry

13th out of 15 stocks

Analyst Opinion: 0.0Community Rank: 3.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












MDJM (NASDAQ:MDJH) Frequently Asked Questions

How has MDJM's stock been impacted by COVID-19 (Coronavirus)?

MDJM's stock was trading at $2.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MDJH shares have decreased by 38.6% and is now trading at $1.81.
View which stocks have been most impacted by COVID-19
.

Are investors shorting MDJM?

MDJM saw a drop in short interest in December. As of December 31st, there was short interest totaling 100 shares, a drop of 99.5% from the December 15th total of 21,500 shares. Based on an average daily volume of 60,300 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the company's stock are short sold.
View MDJM's Short Interest
.

When is MDJM's next earnings date?

MDJM is scheduled to release its next quarterly earnings announcement on Friday, April 15th 2022.
View our earnings forecast for MDJM
.

Who are MDJM's key executives?

MDJM's management team includes the following people:
  • Si Ping Xu, Chairman & Chief Executive Officer
  • Meng Nan Wang, Chief Financial Officer

What other stocks do shareholders of MDJM own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MDJM investors own include IntelGenx Technologies (IGXT), Aemetis (AMTX), J.Jill (JILL), KemPharm (KMPH), Naked Brand Group (NAKD), Ocugen (OCGN), QuoteMedia (QMCI), Vislink Technologies (VISL), Aethlon Medical (AEMD) and Aehr Test Systems (AEHR).

What is MDJM's stock symbol?

MDJM trades on the NASDAQ under the ticker symbol "MDJH."

How do I buy shares of MDJM?

Shares of MDJH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MDJM's stock price today?

One share of MDJH stock can currently be purchased for approximately $1.81.

How much money does MDJM make?

MDJM has a market capitalization of $21.07 million and generates $5.87 million in revenue each year.

How many employees does MDJM have?

MDJM employs 174 workers across the globe.

What is MDJM's official website?

The official website for MDJM is www.mdjhchina.com.

Where are MDJM's headquarters?

How can I contact MDJM?

MDJM's mailing address is SUITE C-1505 SAIDUN CENTER XIKANG ROAD HEPING DISTRICT, TIANJIN F4, 300051. The company can be reached via phone at 862283520851 or via email at [email protected].


This page was last updated on 1/24/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.